A phase 2, multicenter study of TILs treatment in advanced tumors with alterations in the SWI/SNF complex: The TILTS study.

Authors

null

Juan Martin-Liberal

Medical Oncology Department, Catalan Institute of Oncology (ICO), L'hospitalet De Llobregat, Spain

Juan Martin-Liberal , Elena Garralda , Jesus Garcia Donas , Juan Jose Soto , Carles Codony , Silvia Martín-Lluesma , Susana Muñoz , Vladimir Galvao , M. Julia Lostes-Bardaji , Marta Rotxés , Sergio Querol , Luciano Rodriguez , Ainhoa Muñoz , Rafael Moreno , Xavier Garcia del Muro , Ramón Alemany , Alena Gros , Josep M. Piulats

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Cellular Immmunotherapy

Clinical Trial Registration Number

2023-504632-17-00

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS2674)

DOI

10.1200/JCO.2024.42.16_suppl.TPS2674

Abstract #

TPS2674

Poster Bd #

150b

Abstract Disclosures